Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tuomin Zhiti Tang
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tuomin Zhiti Tang (TZD) is a Traditional Chinese Medicine (TCM) decoction composed of multiple herbal ingredients. It is being investigated for the treatment of allergic rhinitis, particularly seasonal allergic rhinitis (SAR). Clinical studies have indicated that TZD can significantly reduce nasal and ocular symptoms associated with allergic rhinitis and improve patients' quality of life. Its proposed mechanism of action involves controlling allergic reactions by reducing OVA-specific IgE and histamine release, and by modulating immune responses, specifically by decreasing interleukin-4 (IL-4) levels and increasing interferon-gamma (IFN-γ) levels. Research also suggests it can alleviate inflammatory responses and enhance immune function.
- Other names
- 脱敏止嚏汤
02
Targets
IgE (Immunoglobulin E)IFNG (Interferon gamma)IL-4 (Interleukin 4)
Beyond the preview
Go deeper on Tuomin Zhiti Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tuomin Zhiti Tang.